|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890<!-- Doctopic: VH -->显示文摘 | Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr | 2013 | Journal of Hepatology2013，，： | 2 |
| 2 | Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients with HCV Genotype 1 Infection显示文摘 | P. Marcellin C. Cooper L. Balart D. Larrey T. Box E. Yoshida E. Lawitz P. Buggisch P. Ferenci M. Weltman E. Labriola-Tompkins S. Le Pogam I. Nájera D. Thomas G. Hooper N.S. Shulman Y. Zhang M.T. Navarro C.Y. Lim M. Brunda N.A. Terrault E.S. Yetzer | 2013 | Gastroenterology2013，，： | 2 |
| 3 | SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders显示文摘 | Christoph Sarrazin Regine Rouzier Frank Wagner Nicole Forestier Dominique Larrey Samir K. Gupta Musaddeq Hussain Amrik Shah David Cutler Jenny Zhang Stefan Zeuzem | 2007 | Gastroenterology2007，，4： | 2 |
| 4 | Epidemiology and Individual Susceptibility to Adverse Drug Reactions Affecting the Liver显示文摘 | Dominique Larrey | 2002 | Semin Liver Dis2002，，02： | 2 |
| 5 | Drug-induced liver diseases 显示文摘 | Larrey D | 2000 | J Hepatol2000，32，： | 1 |
| 6 | Drug- induceda cuteil verfailure显示文摘 | Larrey l) 6eaux 6 P | 2005 | Eur J 6astmenterol Hepatol2005，17，2： | 1 |
| 7 | Possible role of HLA in hepatotoxicity: an exploratory study in 71 pa- tients with drug-induced idiosyncratic hepatitis显示文摘 | Berson A Fr6neaux E Larrey D | 1994 | J Hepa- tol1994，20，3： | 1 |
| 8 | Hepatitis associated with amoxicillin-clavulanic acid combination report of 15 cases显示文摘 | Larrey D Vial T Micaleff A | 1992 | Gut1992，33，3： | 1 |
| 9 | Drug-induced liver diseases显示文摘 | Larrey D | 2000 | J Hepatol2000，32，： | 1 |
| 10 | Hepatitis C virus infection:are there still specific problems with genotype 3?显示文摘Hepatitis C virus(HCV) infection is one of the most common causes of chronic liver disease and the main indication for liver transplantation worldwide. As promising specific treatments have been introduced for genotype 1, clinicians and researchers are now focusing on patients infected by non-genotype 1 HCV, particularly genotype 3. Indeed, in the golden era of direct-acting antiviral drugs, genotype 3 infections are no longer considered as easy to treat and are associated with higher risk of developing severe liver injuries, such as cirrhosis and hepatocellular carcinoma. Moreover, HCV genotype 3 accounts for 40% of all HCV infections in Asia and is the most frequent genotype among HCV-positive injecting drug users in several countries. Here, we review recent data on HCV genotype 3 infection/treatment, including clinical aspects and the underlying genotype-specific molecular mechanisms. | Claire Gondeau Georges Philippe Pageaux Dominique Larrey | 2015 | World Journal of Gastroenterology2015，21，42： | 1 |
| 11 | Epidemilogy and individual susceptibility to adverse drug reactions affecting the liver显示文摘 | Larrey D | 2002 | Sem Dis2002，22，2： | 1 |
| 12 | Hepatic findings in long-term clinical trials of ximelagatran 显示文摘 | LEE W M LARREY D OLSSON R | 2005 | Drug Saf2005，28，4： | 1 |
| 13 | Druginduced acute liver failure显示文摘 | Larrey D Pageaux GP | 2005 | Eurj Gas- troenterol Hepatol2005，17，2： | 1 |
| 14 | Epidemiology and individual susceptibility to adverse drug reactions affevting the liver显示文摘 | Larrey D | 2002 | Semin Liver Dir2002，22，2： | 1 |
| 15 | Drug-induced liver diseases显示文摘 | Larrey D | | 0，，： | 1 |
| 16 | Epidemiology and individual susceptibility toadverse drug reactions affecting the liver显示文摘 | Larrey D | 2002 | Semin Liver Dis2002，22，2： | 1 |
| 17 | Epidemiology and individual susceptibility to adverse drug reactions affecting the liver显示文摘 | Larrey D | 2002 | Semin Liver Dis2002，22，2： | 1 |
| 18 | Drug-induceda cuteil verfa ilure显示文摘 | Larrey D Geaux G P | 2005 | Eur J Gastmenterol Hepatol2005，17，2： | 1 |
| 19 | Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890<!-- Doctopic: VH -->显示文摘 | Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr | 2013 | Journal of Hepatology2013，，： | 1 |
| 20 | Epidemiology and individual susceptibility to adverse drug reactions affecting the liver显示文摘 | | 2002 | Seminars in liver Disease2002，22，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员